Retina Center of New Jersey, LLC
Bloomfield, New Jersey 07003
We've found
8 trials
at this facility
Macular Telangiectasia Type 2 Clinical Trial
Updated: 12/31/1969
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 12/31/1969
Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Macular Degeneration Clinical Trial
Updated: 1/7/2016
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Status: Enrolling,
Phase
I, II
Updated: 1/7/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Ophthalmology Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 12/31/1969
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Updated: 12/31/1969
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials